Related Experiment Video
Updated: May 31, 2025

04:48
Application of Deep Learning-Based Medical Image Segmentation via Orbital Computed Tomography
Published on: November 30, 2022
2.6K
FundusNet: A Deep-Learning Approach for Fast Diagnosis of Neurodegenerative and Eye Diseases Using Fundus Images
Wenxing Hu1, Kejie Li1, Jake Gagnon1
1Research Department, Biogen, Inc., 225 Binney St., Cambridge, MA 02142, USA.
Bioengineering (Basel, Switzerland)
|January 24, 2025
Summary
FundusNet, a deep learning model, offers rapid, cost-effective early detection of neurodegenerative diseases using fundus images. It shows promise in diagnosing Parkinson's and multiple sclerosis, aiding clinical treatment.
Area of Science:
- Ophthalmology
- Neurology
- Artificial Intelligence
Background:
- Early detection of neurodegenerative diseases is critical for treatment.
- Current diagnostic methods are often expensive and time-consuming.
Purpose of the Study:
- To introduce FundusNet, a deep learning model for rapid and cost-effective diagnosis of neurodegenerative diseases using fundus images.
- To evaluate FundusNet's performance in age prediction, gender classification, and diagnosing specific neurodegenerative diseases.
Main Methods:
- A deep learning model, FundusNet, was trained on fundus images.
- Performance was assessed using metrics like Mean Absolute Error (MAE) and Area Under the Curve (AUC).
- Grad-CAM was employed for model interpretability, identifying image regions crucial for diagnosis.
Main Results:
- FundusNet achieved high accuracy in age prediction (MAE 2.55 years) and gender classification (AUC 0.98).
- The model demonstrated significant performance in diagnosing Parkinson's disease (AUC 0.75 ± 0.03) and multiple sclerosis (AUC 0.77 ± 0.02).
- Grad-CAM analysis confirmed FundusNet's focus on relevant retinal structures, and genetic risk prediction showed high accuracy.
Conclusions:
- FundusNet provides a rapid, cost-effective tool for early neurodegenerative disease detection via fundus imaging.
- The model's interpretability highlights its ability to identify disease-associated retinal biomarkers.
- Further enhancement is possible with larger datasets, particularly for predicting genetic risk.

